AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Carmen Inés Rodríguez Cuéllar, Pediatric Nephrologist Department of Pediatrics, Fundación Clínica Shaio Bogotá, Colombia.
Citation: Elisa C. Yoo, Carmen I. R. Cuellar, Ana C. A. Elías, Angie Lizet A. González, Medeiros M. and Filler G., (2021) Hemoglobin and Cholesterol Affect Apparent Tacrolimus Clearance in Pediatric Transplant Recipients – a Retrospective Cohort Study. J Pharmaceutics and Pharmacology Research. 4(2); DOI:10.31579/2693-7247/015
Copyright: © 2021 Carmen Inés Rodríguez Cuéllar, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 20 September 2020 | Accepted: 01 November 2020 | Published: 27 February 2021
Keywords: kidney transplantation, pediatric; tacrolimus, apparent total clearance,high-density lipoprotein cholesterol, hemoglobin and immunosuppression
Introduction: Tacrolimus has a narrow therapeutic index with substantial inter- and intra-patient variability. Factors beyond genetic and developmental factors are poorly understood. Recent adult studies suggest that hemoglobin affects the apparent clearance (CL/F), whereas this and other potential factors in children are understudied.
Methods: After ethics approval, we performed a single center retrospective cohort study of pediatric renal transplant recipients, who were followed between January 1st, 2004, and June 30th, 2018. Patients without tacrolimus therapy or concomitant sirolimus were excluded. The aim was to show the impact of hemoglobin, albumin, cholesterol and HDL on the apparent tacrolimus clearance (CL/F = Dose/AUC). Data were collected from electronic health record. We used 12-point pharmacokinetic (PK) profiles. Results: Thirty-three patients were included. Median age at transplantation was 10 years, 52% were female, the median tacrolimus area under the curve (AUC) was 133 ng*h/mL. CL/F mainly correlated with hemoglobin (n=1,257, r=-0.3767, p<0.0001), HDL-cholesterol (n=236, r=-0.3973, p<0.0001) and total cholesterol (n=373, r=-0.1821, p=0.0004).
Conclusion: The present study suggests a moderate impact of the biochemical factors studied in the tacrolimus CL/F. Lower hemoglobin seems to increase it, while higher cholesterol decreases it. Physicians should be aware of this association during the TDM follow up.
There is growing evidence that under-immunosuppression after renal transplantation; both early and late, may contribute to graft loss. Tacrolimus is a critical dose drug with a narrow therapeutic index for which therapeutic drug monitoring (TDM) is routinely performed. Usually, we aim for a lower tacrolimus concentration as time after transplant increases. Previous studies have shown that there is a significant correlation between the levels and the risk of acute graft rejection [1].
There are multiple factors that affect the pharmacokinetics of tacrolimus. Limited studies in adults suggest that lower hemoglobin increases tacrolimus clearance [2]. The rigor of addressing chronic kidney disease (CKD) related changes such as renal anemia is poorer after transplantation when compared to the management of CKD in native kidneys [3]. The impact of hemoglobin and other biochemical parameters regarding apparent clearance of tacrolimus has been understudied in children. Our study aimed at identifying the possible confounders and their impact on the apparent tacrolimus clearance (CL/F). It was hypothesized that, similar to adults, hemoglobin and albumin would have an effect on tacrolimus clearance. We also hypothesized that similar to adults, total cholesterol and HDL cholesterol would inversely correlate with tacrolimus clearance [4].
The Western University Research Ethics Board (HSREB FileNumber 105148) approved the study and it was conducted in accordance with the declaration of Helsinki.[5-8] we retrospectively analyzed all existing data on 33 pediatric renal transplant recipients who were followed between January 1st, 2004, and June 30th, 2018. This study cohort included all pediatric patients who had undergone renal transplantation <18 n=2),>
Clinical information
Gender, underlying diagnosis leading to end-stage renal failure, age at transplant, follow-up time after transplantation, daily concomitant immunosuppressive and other medication, and anthropometric data (height, weight) were obtained from the patient’s paper and electronic charts. Along with all available tacrolimus concentrations, we used our electronic health record to obtain the following laboratory parameters: cystatin C, creatinine, albumin, hemoglobin, total cholesterol, and high-density lipoprotein (HDL) cholesterol and triglyceride levels. None of the patients had elevated transaminases or elevated bilirubin. Estimated glomerular filtration rate (eGFR) was calculated using the Filler formula [9].
Calculation of the apparent clearance (CL/F) based on estimated Area under the time-concentration curve (AUC)
We had 122 complete 12-point tacrolimus PK profiles of pediatric renal transplant patients which had been described in a previous paper for the calculation of the estimated AUC.[10] We used linear regression to calculate a regression line based on the trough level (see results). The estimated AUC was expressed as
Y=11.8118 * C0+40.56
Where C0 is the pre-dose trough level.
CL/F was calculated using the dose for a dosing interval divided by the AUC using the formula:
CL/F = Dose/AUC
For the CL/F per body weight, we divided CL/F by the body weight. CL/F/kg was calculated dividing CL/F by the body weight of the patient.
Tacrolimus concentration measurements and adjustments
All patients were treated with tacrolimus with concomitant MMF. Tacrolimus was started at 0.15 mg/kg/dose and modified according to the patient’s trough concentrations. We did not adjust for genotype expresser status [11]. Target tacrolimus concentrations were 10-20 ng/mL in the first month post-transplantation, followed by a gradual decrease of the trough concentration to 5-10 ng/mL at one year and 4-6 ng/mL thereafter. Data were only included until the 18th birthday.
Concomitant MMF was started at a dose of 1200 mg/m2 body surface area in 2 divided doses [12]. A higher starting dose was occasionally chosen for small children.
Tacrolimus concentrations were measured with the HPLC/MS/MS. The lower limit of quantification for the tacrolimus concentrations was 2 ng/mL. The total imprecision for all tests was less than 5%.
Statistical analysis
Data were tested for normality using the D’Agostini Pearson Omnibus test. Descriptive data are represented as mean ± one standard deviation (for normal distribution) or as median and 25th and 75th percentile (for non-normal distribution). AUC was measured from a 12-point PK profile using the trapezoid rule [10]. As most parameters were not normally distributed, we used Spearman rank correlation tests to determine which parameters correlated with the apparent clearance (CL/F) in a univariate approach. No adjustments were made for missing values. After the univariate approach, we used mixed effect multivariate regression analysis because of the interdependencies of several factors, for instance, lower albumin yields higher total cholesterol or lower eGFR yields lower hemoglobin, albumin and higher triglycerides [13, 14]. CL/F was used as dependent variable while all significant factors from the univariate analysis were used as independent variables. In the final model, we excluded HDL cholesterol because of the small number of measurements. Constant term was not suppressed, and a correlation matrix was reported.
We also compared our CL/F results with the existing literature, using the one sample t-test. All analyses were performed using Excel (Office for Mac 2011, version 14.3.8), GraphPad Prism for Mac OS X version 5 (GraphPad Software, San Diego, CA, USA) and STATA version 11.2 for Mac (StataCorp, College Station, TX, USA). A p-value <0>
Patient population for the estimated tacrolimus clearance study
Out of the 42 pediatric renal transplant recipients followed during the study period, 33 qualified for the study (Figure 1). The demographic characteristics of the entire cohort are described in table 1. Seventeen of these 33 were female. The median age at transplant was 10.5 years, with a median follow-up of 9.2 years (25th percentile 3.7, 75th percentile 10.0 years). Each patient had a median of 82 tacrolimus trough concentrations (range 10-264). The underlying diagnoses were: renal dysplasia=12, obstructive uropathy or reflux nephropathy=9, focal and segmental glomerulosclerosis=2, autosomal recessive polycystic kidney disease=3, glomerulonephritis= 2, spina bifida=2, cystinosis=1, bilateral Wilms Tumor=1, bilateral renal vein thrombosis=1. Demographic data are summarized in table 1.
Development of the formula for estimation of cl/f
One hundred twenty-two PK profiles were available for the correlation analysis between the AUC and the trough level. Median tacrolimus trough level was 7.8 ng/mL (interquartile range [25-75%]: 5.575-9.825 ng/mL), and median tacrolimus AUC was 130.5 ng*h/mL (interquartile range [25-75%]: 99.5-126.6 ng*h/mL). We plotted the AUC against the trough level (C0). The Pearson correlation coefficient between tacrolimus AUC and C0 was 0.745 (p < 0>
AUC=11.8118 * C0+40.56 (Formula 1)
The Pearson correlation coefficient was 0.745, p<0 xss=removed xss=removed>
We then tested the agreement between the estimated AUC based on the trough level using the formula 1. The mean bias was +2.874%±24.17%, with a 95% limit of agreement from -44.51 to +50.26. Most of the values were within +30% and -30%, which implies a reasonable agreement. Mean bias was 2.874% with 95% limits of agreement from – 44.51 to 50.26% (Figure 3). Based on these findings, we calculated the estimated CL/F using formula 1.
Analysis of estimated auc, cl/f and CL/F/kg
We could calculate 1,914 estimated tacrolimus CL/F. The median tacrolimus trough level was 6.9 ng/mL. The median estimated AUC was 133 ng*h/mL, with a 25th percentile of 100 and a 75th percentile of 174 ng*h/mL. Median CL/F was 28.8 L/h with a range from 2.85 – 163.8 L/h. The 25th percentile was 19.08 L/h, and the 75th percentile was 42.8 L/h. As the average CL/F in adult renal transplant patients had been reported as 21.5 L/h, [2] we compared our findings using a one-sample t-test and found that our median CL/F was not significantly different. One of the few previous pediatric studies by Andrews et al. reported a mean clearance of 50.5 L/h, [15] which was significantly higher in both the one sample t-test and the Wilcoxon signed rank test when compared to our findings. For the CL/F/kg the results were as follows: There were 1,776 measurements with concomitant weight. Median CL/F/kg was 0.502 L/h/kg with a range from 0.073 – 4.05 L/kg. The 25th percentile was 0.332 L/h/kg, and the 75th percentile was 0.787 L/h/kg.
We then performed correlation studies. The results are provided in table 2 for the CL/F. In the univariate analysis, we found some moderate and some weak, but significant correlations of the estimated CL/F with hemoglobin (n{number of observations}=1,257, r=-0.3767, p<0 n=236, n=1,394, r=-0.2002, n=373, r=-0.1821, p=0.0004), albumin n=1,090, r=-0.08911, p=0.0032), n=490, r=0.08877, p=0.0495).>
Finally, we performed mixed effect multivariate regression analysis for CL/F [L/h] on all available observations. Only hemoglobin and cholesterol (Table 3) remained significant. All eGFR markers no longer were significant.
In this retrospective cohort study, we had 3,904 tacrolimus trough levels and multiple PK profiles of 33 renal transplant recipients, for which we could calculate 1,914 CL/F based on the trough levels. The median CL/F was 0.5 L/h/kg or 28.84 L/h, similar to that found in adults [2]. The average CL/F in adult renal transplant patients had been reported as 21.5 L/h [2]. Our results were lower than those from one of the few previous pediatric studies performed by Andrews et al., who reported a mean clearance of 50.5 L/h [15]. As the clearance often is not normally distributed, one possible explanation for the difference may be due an overestimation by reporting the mean. Furthermore; this difference may be attributable to 40% of CYP 3A5 expressers in that cohort [15]. In our cohort, we had only one identified CYP 3A5 expresser who was only tested because of the excessive requirements of up to 26 mg of tacrolimus per day, and most patients have not been tested. For stem cell transplant recipients, Przepiorka et al. found a CL/F for patients < 6 years to be 0.159±0.083 L/h/kg, for 6 to 12 years old of 0.109±0.053 L/h/kg and for > 12 years of 0.104±0.068 L/h/kg using continuous intravenous tacrolimus. These values were significantly lower than the one observed in our study. The intravenous application explains the lower CL/F as bioavailability is lower in oral administration likely caused by pre-systemic metabolism [16-18]. Given that the average oral bioavailability of tacrolimus is between 4 and 89%, our values fit those of Przepiorka [18]. The Bland &Altman analysis revealed a reasonable agreement, suggesting that our estimation of CL/F based on the trough level may be a reasonably accurate estimation of the apparent clearance.
Using univariate correlation analysis, estimated tacrolimus CL/F was moderately correlated with hemoglobin, HDL-cholesterol, and weakly with correlated with total cholesterol, creatinine, albumin and cystatin C. There was no significant correlation with triglycerides and eGFR. Using mixed model regression multivariate analysis, CL/F was still independently affected by hemoglobin and cholesterol. We are unaware of any pediatric study that analyzed the relationship between CL/F and hemoglobin or cholesterol.
To understand these findings, we need to review the pharmacokinetic characteristics of tacrolimus. Bioavailability of tacrolimus after oral administration varies between 4 and 89% and is most likely caused by pre-systemic metabolism in gut wall and liver [16]. Tacrolimus is highly bound to red blood cells, 1-α- acid glycoprotein and albumin [16]. Eventually, tacrolimus is eliminated via metabolism by CYP-3A enzymes in both the liver and gut wall [16]. It has been demonstrated that CYP3A5 expressers require at least a 1.5-fold higher tacrolimus dose compared to CYP3A5 non-expresser [15]. Renal elimination is negligible as <1% of an intravenous dose is excreted in urine in unchanged forms [16].
The impact of hemoglobin has been previously described in adult patients only [19]. The higher the level of hemoglobin, the lower the clearance of tacrolimus [19]. Binding of tacrolimus to erythrocytes restricts its availability for metabolism [20] de Jonge, et al. demonstrated that after kidney transplantation the continued increase in hematocrit explained 23.6% of the further decline in mean tacrolimus CL/F [19].
Anemia after kidney transplantation shows a biphasic pattern. Early after the surgical procedure many transplant patients are anemic. Hemoglobin levels increase with the restoration of kidney function during the first 3 months. But even despite a good a stable graft function anemia can be present in 10 – 42% of patients after the first post-transplant year [21]. These findings can explain the higher clearance of tacrolimus found in post kidney transplant patients related with anemia despite normal eGFR [21].
We also found a relationship between total cholesterol, HDL-cholesterol and tacrolimus CL/F. Zahir et al. described in adults patients that an increase in cholesterol is associated with lower unbound tacrolimus level and a lower CL/F [4]. Our findings are in agreement with Zahir’s observations. Tacrolimus mainly associates with soluble proteins and also with HDL, LDL, and VLDL. The association of tacrolimus with HDL is almost 30% [4]. Zahir et al. hypothesized that tacrolimus is covalently bound to HDL which decreases its CL/F [4]. It has been reported that over the post transplant period there is an increase in HDL and VLDL fractions in renal transplant patients receiving tacrolimus [4]. We are unaware of any description of this relationship in pediatric patients.
Our study has several limitations. The retrospective nature of the study forms a significant limitation. However, such a large number of tacrolimus CL/F measurements would not be easily obtained in prospective studies. The lack of complete pharmacokinetic profiles for every time point is a shortcoming as is the fact that we estimated CL/F from trough levels. However, the number of 122 full PK profiles compares favorably with other studies, and the Bland & Altman analysis suggests a reasonable accuracy of our calculations. As this was not a planned study, there is wide interpatient variability of the number studies regarding albumin, hemoglobin, eGFR and lipid studies in these patients. Nonetheless, the large number of CL/F measurements over a long follow-up forms a considerable strength. The findings may also not be generalizable because of the low number of CYP 3A5 expressers in our population. Lastly, as shown by de Jonge, tacrolimus CL/F increases over time over the first 12 months after transplantation, possibly due to a decrease of the CYP3A4 activity [19]. Another explanation could be the concomitant change of the steroid drug interaction [7] or developmental changes [8]. The study was not designed to look specifically at the ongoing temporal trends over the much longer follow-up period in our study. In the first year, hemoglobin typically increases but then decreases again over time as renal function worsens.[22] In some studies hemoglobin may drop again even if renal function is normal [21].
The current study highlights the moderate impact of anemia, HDL and total cholesterol on the tacrolimus CL/F in pediatric renal transplant patients. While lower hemoglobin increases the tacrolimus CL/F, higher cholesterol decreases the tacrolimus CL/F. Transplant physicians should carefully monitor and recognize the high risk of anemia in renal transplant patients and its effects on tacrolimus CL/F. Another important factor that should be observed by physicians include total and HDL cholesterol levels as higher levels decreased estimated tacrolimus CL/F in our study. Most importantly, renal function will decline over time after transplantation, and with worsening eGFR, hemoglobin will decline [3]. As anemia is often undertreated in these patients, the increased clearance of tacrolimus may further add to shorter allograft survival as anemia may be associated with tacrolimus underexposure. We recommend checking tacrolimus levels rigorously in the setting of anemia and possibly considering increasing the Tacrolimus dose or treating the anemia.
We want to acknowledge the staff of the laboratory at London Health Sciences Centre for their excellent and precise analytical work. We want to thank Virginia Schumann at The Lilibeth Caberto Kidney Clinical Research Unit, Victoria Hospital, London, ON for her assistance of the administration of the study.
All authors had no relationships or circumstances that present a potential conflict of interest.
GF conceived the study, applied for the ethics submission, was involved in all aspects of the paper generation and revised each draft, performed the statistical analysis, and coordinated all coauthors’ activities. EY, GF and CIRC performed the statistical analysis, interpreted the data and wrote the first draft. CIRC and EY collected and interpreted the data. MM, ACAE and ALAG provided critical input into all aspects of the design and execution of the study and participated in all phases of the paper writing. All authors participated in revising the manuscript critically for important intellectual content and approved the final version to be submitted to the journal.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
